KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Sarepta Therapeutics (SRPT) Income from Continuing Operations (2016 - 2025)

Sarepta Therapeutics has reported Income from Continuing Operations over the past 15 years, most recently at 352818000.0 for Q4 2025.

  • Quarterly results put Income from Continuing Operations at 352818000.0 for Q4 2025, up 122.23% from a year ago — trailing twelve months through Dec 2025 was 77701000.0 (down 133.07% YoY), and the annual figure for FY2025 was 77711000.0, down 133.07%.
  • Income from Continuing Operations for Q4 2025 was 352818000.0 at Sarepta Therapeutics, up from 179949000.0 in the prior quarter.
  • Over the last five years, Income from Continuing Operations for SRPT hit a ceiling of 352818000.0 in Q4 2025 and a floor of 516710000.0 in Q1 2023.
  • Median Income from Continuing Operations over the past 5 years was 32438500.0 (2023), compared with a mean of 29848150.0.
  • Peak annual rise in Income from Continuing Operations hit 2940.57% in 2025, while the deepest fall reached 1338.98% in 2025.
  • Sarepta Therapeutics' Income from Continuing Operations stood at 249334000.0 in 2021, then crashed by 42.99% to 142140000.0 in 2022, then skyrocketed by 130.0% to 326928000.0 in 2023, then plummeted by 51.44% to 158759000.0 in 2024, then surged by 122.23% to 352818000.0 in 2025.
  • The last three reported values for Income from Continuing Operations were 352818000.0 (Q4 2025), 179949000.0 (Q3 2025), and 196938000.0 (Q2 2025) per Business Quant data.